Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle

A compound, oxadiazole technology, applied in the field of anti-tumor activity, containing 1, can solve problems such as limiting clinical application

Active Publication Date: 2010-11-24
山东康瑞健医疗技术有限公司
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the toxic and side effects of EA such as diuresis and ototoxicity limit its clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle
  • Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle
  • Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] The preparation method of the general formula 5 containing 1,2,4-oxadiazole α,β-unsaturated ketone compound of the present invention, the steps are as follows:

[0035] 1) Preparation of substituted amidoxime (2)

[0036] Add hydroxylamine hydrochloride to anhydrous methanol, add 0.8mL of anhydrous methanol to every millimole of hydroxylamine hydrochloride, then add anhydrous potassium carbonate, react at room temperature until no bubbles are formed, then add substituted benzonitrile (1). The molar ratio of hydroxylamine hydrochloride, anhydrous potassium carbonate and substituted benzonitrile is 5:5:1. Reflux reaction for 4-7h, filter while hot, wash the filter cake with anhydrous methanol, combine the washing liquid and filtrate, evaporate the solvent under reduced pressure, and separate the substituted amidoxime (2) by column chromatography, the elution system is petroleum ether / acetone 3:1 volume ratio.

[0037] 2) Preparation of 2-[2,3-disubstituted-4-(2-methylen...

Embodiment 1

[0051] 1) Preparation of substituted benzamide oxime compound (2)

[0052] Put 3.48g (50mmol) of hydroxylamine hydrochloride and 6.90g (50mmol) of anhydrous potassium carbonate in a 100mL round bottom flask, add 40mL of anhydrous methanol, and react at room temperature until no bubbles are generated, then add 1.71 g of p-substituted benzonitrile (5c) g (10 mmol). Slowly raise the temperature to 65°C, react for 4-7h, filter while hot, wash the filter cake with anhydrous methanol, combine the washing liquid and filtrate, remove the solvent by rotary evaporation, dry, and separate by column chromatography to obtain the intermediate substituted benzamide oxime, The elution system is petroleum ether / acetone 3:1 volume ratio.

[0053] Substituted benzonitrile selects 4-trifluoromethylbenzonitrile, 2-methylbenzonitrile or 4-nitrobenzonitrile respectively, obtains the following substituted benzamide oxime compound (2) respectively:

[0054] 2a: 4-trifluoromethylbenzamide oxime, whit...

Embodiment 2

[0080] Example 2. Compound GST P1-1 Inhibitory Activity Test and Determination of Growth Inhibition of HL-60 Cells

[0081] GST P1-1 inhibitory activity assay method: refer to CN1706789 "α, β-unsaturated ketone compound and its preparation method and its inhibition of GSTπ activity" 200510043573.3, Example 5 on page 11 of the specification.

[0082] HL-60 cell growth inhibitory activity assay method: refer to CN101108832 "Five-membered Heterocyclic Compounds, Preparation Method and Application", 200710015199.5, page 3 of the instruction manual. Human Acute Promyelocytic Leukemia Cell Line (HL-60)

[0083] Table 1. Determination data of compounds inhibiting GST P1-1 activity and inhibiting HL-60 cell growth activity

[0084]

[0085]

[0086] Experimental results show that most of the 1,2,4-oxadiazole α,β-unsaturated ketone compounds of the present invention have a half-inhibitory concentration of HL-60 cells less than or equal to 2.0 μM, and the activity is further impr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an alpha, beta-unsaturated ketone compound containing a 1,2,4-oxadiazoles heterocycle, the structure of which is as shown in general formula 5, wherein R1 is hydrogen, methyl or chlorine; R2 is methyl, chlorine or bromine; R3 is methyl or ethyl; R4 is para-trifluoromethyl, ortho-methyl or para-nitro; and R5 is hydrogen or methyl. The invention also provides a preparation method of the compound and application thereof. The half-growth inhibitory concentration of the compound on HL-60 cells is less than or equal to 2.0 mu M, and the activity is obviously improved, thus the compound can be used for preparing antileukemie medicaments.

Description

technical field [0001] The invention relates to the fields of organic compounds and medical applications, in particular to α, β-unsaturated ketone compounds containing 1,2,4-oxadiazole heterocycle and their antitumor activity. Background technique [0002] Malignant tumor is one of the major diseases that threaten human health in the world today. With the development of tumor biology, it provides a new molecular biological basis for the research and development of antitumor drugs. Most tumor cells highly express glutathione S-transferases (GSTs). GSTs are a multifunctional protein superfamily widely present in eukaryotes and are usually divided into cytosolic family, mitochondrial family and membrane-bound protein family. Microsomal family, see: Hayes, J.D.; Flanagan, J.U.; Jowsey, I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 51-88. Mammalian cytosolic GSTs can be divided into seven subtypes: Alpha (α), Mu (μ), Pi (π), Sigma (σ), Omega (ω), Theta ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D271/06A61K31/4245A61P35/02
Inventor 赵桂森杨新美李红彩李婷刘古月张林娜
Owner 山东康瑞健医疗技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap